Korea pushes R&D of infectious disease therapeutics and vaccines
Singapore, April 12 -- The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) have signed a memorandum of understanding (MOU) for mutual collaboration in the research and development of therapeutics and vaccines for infectious diseases.
Towards the shared goal of improving public health, the IPK and IVI will promote research collaboration and information exchange, holding joint workshops and seminars to connect biomedical scientists and infectious disease experts of the two organizations and their partners worldwide.
In particular, the collaboration combines IPK's research and technology in infectious disease and IVI's capabilities and know-how in developing and designing new vaccines and in supporting clinical t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.